PC-2 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Neuroendocrine Convertase 2 (PCSK2/PC-2, UniProt P16519) expressed in HEK293 cells. Suitable for serine endopeptidase activity assays, inhibitor profiling, and antibody validation studies.
Expression system
HEK293
Cat. #
REC-PC2

In stock

SKU
REC-PC2
$498.00

Target Overview

PC-2 (Proprotein Convertase Subtilisin/Kexin Type 2; UniProt P16519) is a calcium-dependent serine endopeptidase of the subtilisin-like proprotein convertase family. The full-length human PCSK2 gene encodes a 638-amino-acid precursor that is processed through autocatalytic removal of its prodomain before reaching enzymatic competence. This recombinant form is expressed in HEK293 mammalian cells, providing the post-translational processing and glycosylation environment appropriate for a secretory-vesicle–resident enzyme. PC-2 cleaves precursor proteins at pairs of basic residues (typically Lys-Arg or Arg-Arg motifs), making it the principal convertase responsible for processing proglucagon to glucagon in pancreatic alpha cells and for contributing to proinsulin-to-insulin maturation. Its restricted expression to neuroendocrine and neuronal tissues distinguishes it from the more broadly expressed PC-1/3 convertase. In the laboratory, recombinant PC-2 is used in several experimental contexts. Substrate cleavage assays — using fluorogenic peptides or natural precursor substrates — allow direct measurement of endopeptidase activity and determination of kinetic parameters (Km, kcat). Inhibitor screening experiments use purified enzyme to generate IC50 values against small-molecule or peptide-based candidate inhibitors. Researchers validating antibodies raised against PCSK2 use this recombinant as a positive-control antigen in Western blot, dot-blot, and ELISA formats; it pairs directly with the Triple Point Biologics matched antibody (SKU: RP-PC2) for that purpose. The HEK293 expression system also makes this recombinant suitable for biophysical studies — surface plasmon resonance, isothermal titration calorimetry, or native PAGE — where correct folding and glycosylation are required for meaningful binding data.

Background

Neuroendocrine Convertase 2 (PC-2; gene PCSK2) is a member of the calcium-dependent, subtilisin-related serine endoprotease family. It is expressed predominantly in pancreatic islet cells, anterior pituitary, and discrete neuronal populations, where it resides in secretory vesicles and processes a spectrum of peptide hormone and neuropeptide precursors. PC-2 cleaves after paired basic residues — predominantly at Lys-Arg and Arg-Arg motifs — and requires 7B2 (secretogranin V) as a binding partner for proper folding and export from the endoplasmic reticulum. The most extensively studied substrates of PC-2 are proglucagon and proinsulin. In pancreatic alpha cells, PC-2 is the convertase primarily responsible for liberating mature glucagon from proglucagon; disruption of this processing step is under active investigation as a contributor to dysglycemia. Shrestha et al. (2025, PMID: 40345205) used stem cell–derived alpha cells to model diabetic alpha cell dysfunction, a system in which PCSK2 expression and proglucagon processing are central readouts, illustrating how recombinant PC-2 and matched antibody tools support mechanistic dissection of alpha cell biology. Taneera et al. (2026, PMID: 41359828) examined proteomic shifts in INS-1 beta cells following PPP1R1A knockdown, identifying modulation of pathways relevant to insulin granule maturation where PC-2 activity is a functional node. Beyond glucose homeostasis, PCSK2 has been identified as one of several lymph node metastasis–related genes in pancreatic adenocarcinoma (Shu Q, 2025, PMID: 41431044), associating its expression pattern with immune cell infiltration signatures and ferroptosis-related gene sets — findings that position it as a research target in the context of pancreatic cancer biology. Separately, genome-wide association studies in South Korean adults have flagged PCSK2 locus variants among candidates associated with type 2 diabetes risk (Oh J et al., 2025, PMID: 40141237), consistent with the enzyme's documented role in islet hormone maturation. Triple Point Biologics has produced antibodies targeting proteinases and their inhibitors since 1994. Researchers using REC-PC2 for antibody validation can pair it directly with the matched Triple Point antibody (SKU: RP-PC2), validated for Western blot against human PCSK2, with predicted cross-reactivity to mouse, rat, and several other species. All disease associations described here reflect published basic research contexts and are not therapeutic claims.

Applications

  • Fluorogenic peptide substrate cleavage assay to measure PC-2 serine endopeptidase activity (Km and kcat determination)
  • Inhibitor IC50 profiling against small-molecule or peptide-based PCSK2 inhibitor candidates
  • Positive-control antigen for Western blot validation of anti-PCSK2 antibodies (pairs with RP-PC2)
  • ELISA capture or detection standard for PCSK2 quantification assays
  • Proglucagon or proinsulin precursor processing assay to confirm substrate specificity
  • Surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) binding studies with candidate interactors or 7B2 cofactor
  • Dot-blot or immunoprecipitation positive control in neuroendocrine or islet cell proteomics workflows

References

  1. Shu Q. The prognostic significance of lymph node metastasis-related genes in pancreatic adenocarcinoma is associated with immune cell infiltration and ferroptosis. Medicine (Baltimore). 2025. doi:10.1097/MD.0000000000046435. PMID: 41431044.
  2. Taneera J et al. Impact of PPP1R1A Knockdown on the Proteomic Landscape of INS-1 Cells: A Focus on Significant Modulated Pathways. J Proteome Res. 2026. doi:10.1021/acs.jproteome.5c00889. PMID: 41359828.
  3. Ahmed NA et al. (-)-Oleuropein as a Novel Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence Suppressor via Targeting PCSK9-LDLR Axis. Nutrients. 2025. doi:10.3390/nu17091445. PMID: 40362754.
  4. Shrestha S et al. Modeling diabetic alpha cell dysfunction using stem cell-derived alpha cells. Stem Cell Reports. 2025. doi:10.1016/j.stemcr.2025.102504. PMID: 40345205.
  5. Oh J et al. Identification of Novel Genetic Variants and Food Intake Factors Associated with Type 2 Diabetes in South Korean Adults, Using an Illness-Death Model. Int J Mol Sci. 2025. doi:10.3390/ijms26062597. PMID: 40141237.

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Subcellular localization not yet annotated

Frequently Asked Questions

What is the expected molecular weight of recombinant PC-2 on SDS-PAGE and Western blot?

The full-length human PC-2 precursor is 638 amino acids (~71 kDa predicted), but the mature, prodomain-cleaved form that reaches enzymatic competence runs at approximately 66–68 kDa under reducing SDS-PAGE conditions. Because this recombinant is expressed in HEK293 cells, N-linked glycosylation adds an additional 3–6 kDa of apparent mass, so expect a diffuse band in the 69–74 kDa range on Western blot. A faint higher-MW band representing incompletely processed precursor may also appear, particularly at higher loads.

Which processing form of PC-2 is this recombinant — full precursor, prodomain-cleaved, or mature enzyme?

This preparation corresponds to the autocatalytically processed, prodomain-removed mature form of PC-2 — the enzymatically competent species found in secretory vesicles. The prodomain (~9 kDa) is cleaved intramolecularly during transit through the Golgi/trans-Golgi network and is absent in the final product. HEK293 expression was chosen specifically because it recapitulates the regulated secretory pathway, enabling authentic prodomain removal and glycosylation that bacterial or insect-cell systems cannot provide for this calcium-dependent enzyme.

What substrates does PC-2 cleave and what cleavage motif should I design into a synthetic peptide substrate?

PC-2 cleaves after paired basic residues, with a strong preference for Lys-Arg↓ and Arg-Arg↓ motifs at the P1–P2 positions. For a fluorogenic activity assay, the peptide substrate Boc-Arg-Val-Arg-Arg-AMC (or the closely related pGlu-RTKR-AMC) is commonly used and produces a measurable increase in AMC fluorescence (Ex 380 nm / Em 460 nm). Physiological substrates include proglucagon (cleavage at the GLP-1 and glucagon junctions) and proopiomelanocortin. If designing a custom substrate, ensure a P4 position with a small or basic residue for optimal kcat/Km.

What buffer conditions and calcium concentration are optimal for a PC-2 activity assay?

PC-2 is a calcium-dependent serine protease with an absolute requirement for Ca²⁺ for proper active-site conformation. For in vitro activity assays, use 50 mM sodium acetate or MES pH 5.5–6.0 (reflecting the trans-Golgi/secretory vesicle environment) supplemented with 1–5 mM CaCl₂. The enzyme is largely inactive at neutral pH — activity drops sharply above pH 7.0. The storage buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol) is not suitable as an assay buffer; dilute into your pH 5.5–6.0 assay buffer immediately before use.

What starting concentration of recombinant PC-2 should I use for a fluorogenic peptide cleavage assay?

A useful starting point is 50–200 nM recombinant PC-2 in a 100 µL assay volume, with substrate (e.g., Boc-Arg-Val-Arg-Arg-AMC) at 50–200 µM. At 100 nM enzyme and 100 µM substrate in 50 mM sodium acetate pH 5.8 / 2 mM CaCl₂ / 0.01% Triton X-100, AMC release is typically linear for 30–60 minutes at 37°C. Titrate enzyme concentration to keep initial velocity in the linear range before running inhibitor panels or IC₅₀ experiments. Include a no-enzyme and a heat-inactivated control in each plate.

Can I use PC-2 (Recombinant) as a Western blot positive control for the RP-PC2 matched antibody?

Yes — that is a primary validated use case for this product. Load 20–50 ng of recombinant PC-2 per lane alongside your cell or tissue lysates. The matched rabbit polyclonal antibody RP-PC2 (see /anti-pc-2-rabbit-polyclonal-antibody) is raised from the same antigen preparation used to characterize this recombinant, so band identity and apparent MW are directly comparable across experiments. This pairing is particularly useful when setting up detection in new tissue types or when troubleshooting weak endogenous signal in non-neuroendocrine cell lines that express PC-2 at low levels.

How much recombinant PC-2 should I load for a positive control lane when validating the RP-PC2 antibody?

For routine Western blot antibody validation, load 25–50 ng per lane. At 25 ng with RP-PC2 at a 1:1,000–1:2,000 dilution, you should observe a clean band at ~69–74 kDa after standard 1-hour ECL exposure on PVDF membrane. If you are titrating antibody concentration or comparing lot-to-lot performance, a 3-point dilution series (10 ng, 25 ng, 50 ng) of this recombinant alongside islet cell or hypothalamic lysate provides an informative dynamic-range reference. Do not exceed 100 ng per lane — overloading can cause smearing that obscures glycosylation heterogeneity.

How should I handle, dilute, and store recombinant PC-2 to preserve activity across multiple experiments?

The protein is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol and stored at -20°C in single-use aliquots. Avoid repeated freeze-thaw cycles — each cycle measurably reduces specific activity for calcium-dependent serine proteases. Upon receipt, aliquot immediately if the supplied format does not match your per-experiment volume. For activity assays, dilute into cold assay buffer immediately before use and equilibrate to 37°C just prior to the reaction. Purity is >95% by SDS-PAGE; endotoxin is <0.1 EU/µg by LAL assay, making this preparation suitable for cell-based and primary culture experiments.

Validation imagery coming soon

Western blot validation figures for REC-PC2 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →